| Name | Title | Contact Details |
|---|
GE Software is leading efforts to harness the power of the Industrial Internet, building off our powerful mix of industrial machine expertise, historical perspective, and software innovation. The Industrial Internet is changing the way we manage and maximize global economic output. For the first time in human history, critically important machines across the globe are communicating in real time. Combining these brilliant machines with best-in-class analytics delivers valuable new customer insights that were never before possible. GE`s investment in the Industrial Internet is spearheaded by the GE Software Center. This global innovation hub centered in San Ramon, California, is backed by 10,000 software professionals from across GE`s businesses around the world. Together, we are creating GE`s Predictivity™ solutions designed to save customers time, energy, and money.
At Colt Data Centre Services, we aspire to our customers` success, ensuring your growth is supported by the best infrastructure solution for your business` unique vision. We have designed, built, managed and innovated data centres for more than 15 years, and still managed to remain agile in the way we operate `globally`. We combine our certified operational excellence with years of experience and grounding to deliver globally-scalable data centres in a highly dynamic IT environment.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Hubilo is a market leader in the Virtual and Hybrid event platform space. Hubilo is helping organisations across the world reimagine the future of events and navigate an emerging event landscape.